An Observational Chart Review Study To Describe The Real-World Outcomes And Use Of Avelumab In Combination With Axitinib For Treatment Of Patients With aRCC In The UK
Clinical trial NCT05394493 · COMPLETED
Trial details
- NCT number
- NCT05394493
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-11
- Primary completion
- 2023-08-30
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.